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Material and methods. The new image guided AlignRT system is based on structured light. A protocol has been developed to
establish tolerances for accepting patient positioning and to control possible changes in the treatment volume, taking into
account the information given by the AlignRT. We performed a prospective study in a group of patients diagnosed with breast
cancer with indication for breast irradiation after conservative surgery. We collected and corrected in real time the deviations
recorded in the conventional positioning of the patient. Patients who have undergone signiﬁcant changes in the volume of
treatment have been replanned.
Result. By analyzing the recorded correction values, which ensures correct daily positioning of the patient, we observe variations
above one centimeter at some parameters. To adequately cover the ranges associated with treatment volume, we determined
that the percentage of matching treatment-planning surfaces within a tolerance of 3mm should be above 70%. The use of the
system has allowed recording changes in the volume and the determination of treatment replanning in 10–30% of patients,
depending on the time elapsed between the planning CT and the start of treatment. Furthermore we achieved to decrease the
time necessary to guarantee correct daily positioning.
Conclusions. This system ensures proper IGRT daily reproduction treatment, reduces the time necessary to allow patient posi-
tioning and show treatment volume disturbances. Furthermore, it is an innocuous system for the patient.
http://dx.doi.org/10.1016/j.rpor.2013.03.080
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Introduction. Conservative surgery and irradiation can impact in cosmesis results in breast cancer. Several subjective evaluation
scales are currently employed but there are paucity data about cosmesis valuated by objective parameters of skin toxicity. We
present an analysis of cosmetic results in front to measurable parameters of chronic skin toxicity.
Material and methods. Breast cancer patients with conservative surgery have been included and treated postoperatively with
standard or hypofrationated schedules. All patient had a boost at two dose levels. After a minimum follow-up of 12 months,
chronic toxicity was evaluated by RTOG scale, cosmesis results were valuated independently by patient (0–10 scale) and physician
(four grade Harris scale). Objective hydration and elasticity parameters were obtained by means a multi probe skin tester (Multi-
Skin-Center® MC-750-B2, CKelectronic-GmbH).
Results. 39 patients were included in the study. In 26 patients high dose boost was administered (16 or 20Gy) and low dose in the
remaining 13 (dose of 8 or 10Gy). Cosmesis score was of 4–6 in 3 patients, 7–8 in 18 patients, and 9–10 in 18 patients. Objective
parameters at involved breast compared with chronic toxicity and cosmesis scales resulted in no differences between groups.
Nevertheless, when analyzed objectivemeasures at involved boosted quadrant, elasticity and hidration resulted different accord-
ing to patient cosmesis valuation (p=0.022 and 0.035 respectively). Likewise, elasticity decrease at boost level was correlated with
physician valuated cosmesis. There were no correlation of these parameters with toxicity scales or total doses administered at
tumor bed.
Conclusions. Objective evaluation of chronic toxicity by means skin elasticity and hidration parameters could predict long term
cosmetic results.
http://dx.doi.org/10.1016/j.rpor.2013.03.081
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Objective. Considering the radiotherapeutical process as a balance of costs and beneﬁts, we present the results of a pilot study
intended to achieve practical criteria for deciding the appropriate technique for each breast radiotherapy case.
Methods. 21 patients (11 left breast, 3 right; 5 left chest wall, 2 right; 7 of them including axilo-supraclavicular lymph nodes) were
planned to 50Gy with three different techniques in a Pinnacle planning system, according to RTOG-1005 criteria: ﬁrst, named
as classical, two wedged tangential beams; second, named as segmented, a combination of two unwedged tangential ﬁelds
with additional two ﬁelds (gantry varied 10–30 degrees from prior, blocking with MLC the chest wall, heart and lung), adding
two or more ﬁelds for homogeneity if necessary; third, inverse DMPO IMRT. We performed a Wilcoxon statistical analysis of the
data extracted from the histograms, including PTV and separated tumour volumes, as well as the organs at risk (OAR; heart,
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contralateral breast, humeral head, spinal cord, skin and ipsolateral lung). We also compared the uniformity and the van’t Riet
conformation indexes.
Results. Comparing the techniques by pairs, the results indicated that the segmented technique is superior to classical for breast-
only cases, specially for left breasts due to heart sparing. No signiﬁcances were observed for chest wall and lymph nodes cases
except better avoidance of OAR dose for segmented. IMRT is statistically better than classical for all kind of cases, though it carries
more low doses for OAR. Finally, IMRT is superior to segmented for breast-only and lymph nodes cases, but they are statistically
equiparable for chest walls. Again IMRT supposes more low doses for OAR.
Conclusion. This pilot study has given us a better understanding of the capabilities of every technique and helped us decide the
most appropriate dosimetric planning protocol for every breast case.
http://dx.doi.org/10.1016/j.rpor.2013.03.082
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Introduction. The management of information is crucial to optimize the operation of Breast Functional Units and ensure the
success of personalized medicine.
Objective. To have an advanced tool that allows the “integration of all the information generated by the services” involved in Breast
Functional Units, including the service of Radiation Oncology. Providing professionals a support system for clinical decision
helping them to decide what to do with the patient, during diagnosis, prognosis and treatment of the disease and enabling
personalized healthcare.
Material and methods. Task groups with all specialties, analyzing their structure, protocols, records and workﬂow between profes-
sionals, obtaining a collection of requirements to implement in the new information system. Prototypes are developed to validate
the interfaces, functionality and usability of the ﬁnal product, ensuring alignment with existing coding standards, procedures
and health information technology.
Results. Platform “patient-oriented” to improve the effectiveness of exchange of information and knowledge between profession-
als, offering a centralized view of the disease in real time and support tools for decision based in semantics. The obtained tool
is aligned with the following elements: • Electronic medical records; • Conﬁdentiality; • Collaborative work between different
services; • Support for professionals (ontologies to propose and guide in clinical decision); • Improving the quality of information
handled and the time spent in the query.
Conclusions. The new platform will provide to the professionals of the services involved in the diagnosis and treatment of breast
cancer, a new way of working, based on information technologies. Semantic ontologies have been implemented oriented to the
healthcare environment in the areas of diagnosis, individualized treatment and clinical decision support.
http://dx.doi.org/10.1016/j.rpor.2013.03.083
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Introduction. Breast-conserving therapy is the standard of care for early breast cancer. The conventional technique of radiotherapy
includes irradiation to the whole breast followed by a tumour bed boost. Reducing the overall treatment time could decrease the
inconvenience to the patient.
Objective. To evaluate toxicity, cosmetic result and survival in patients with breast cancer treated with radiotherapy and con-
comitant boost to the tumour bed in our centre between 2007 and 2009.
Methods. Descriptive and retrospective analysis. All patientswere treatedwith 3D-conformal external radiotherapy. They received
50Gy to the whole breast, 2Gy per fraction, 5 fractions per week. Toxicities were scored according to the common toxicity criteria
version 4.
Results. 196 patients underwent radiotherapy with concomitant boost between September of 2008 and April of 2010. We collected
data from 162 patients. Median follow-up was 30 months. Median age 52 years, the majority of cases were: postmenopausal
women (54%), ductal histology (75.3%), hormone receptor-positive (81%), HER-2-negative (79%), stage I-IIA (72%). Patients under-
went tumorectomy in 91% and axillar surgery in 73.5%. In 39 patients boost daily doses was 0.53Gy and 0.34Gy in 123 women.
The most common acute toxicity was radiodermitis grade 1 (49.4%) and ﬁbrosis grade 1–2 was the most frequent late toxicity.
